Posted on 2/04/2025
02 April 2025 | In response to demand growth, Rayner – a global leader in solutions for cataract surgery – has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs) it can manufacture annually to 4 million. Since opening its purpose-built manufacturing facility in 2017, every Rayner
Posted on 25/03/2025
In a major step toward redefining postoperative care and elevating patient experience, Rayner – a global leader in cataract surgery products – proudly announces the successful completion of its pivotal U.S. dropless cataract surgery study. OMIDRIA (phenylephrine and ketorolac intraocular solution 1% / 0.3%) is the only FDA-approved NSAID for use during cataract surgery, indicated
Posted on 3/02/2025
03.02.25 | Just 18 weeks on from the first implantation, Rayner is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the RayOne Galaxy intraocular lens in the USA. Developed in collaboration between Rayner, a global manufacturer of cataract surgery solutions, and ophthalmologist Dr João Lyra from
Posted on 23/01/2025
Mississauga, ON | 21 January 2025 Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled
Posted on 15/01/2025
In September 2024, Rayner – a global manufacturer of products for cataract surgery based in the UK – unveiled the world’s first spiral IOL at the ESCRS congress in Barcelona. Today, following a large-scale multicentre data collection study, Rayner announces the full commercial release of RayOne Galaxy and RayOne Galaxy Toric, marking a wider global
Posted on 8/01/2025
Rayner, a global manufacturer of products for cataract surgery, today announces the launch of its redesigned online premium IOL calculator, RayTrace. One of the first online IOL calculation tools, RayTrace has been trusted by surgeons globally since 2008 for the accuracy of its premium IOL (toric, multifocal and supplementary) calculations, and has delivered over 360,000
Posted on 13/12/2024
Midland Eye, a private ophthalmology clinic based in Solihull, UK, were proud to become the first customer globally to receive the Sophi Phaco-emulsification machine following its acquisition by Rayner earlier this year. Worthing-based Rayner, a global manufacturer of products for cataract surgery, acquired Swiss-based This AG, the developer and manufacturer of Sophi, in January 2024.
Posted on 1/10/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, announces today that it has successfully implanted the first lenses in the RayOne Galaxy IOL U.S. Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) Study. The study is prospective, multicenter, randomised, masked and active controlled. If successful, the results of
Posted on 27/08/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces the upcoming launch of the world’s first spiral IOL designed with artificial intelligence: RayOne Galaxy and Galaxy Toric. Launching at this year’s ESCRS Congress in Barcelona, the RayOne Galaxy IOL comes to market precisely 75 years after Rayner pioneered the
Posted on 27/06/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the EMV Toric Intraocular lens in the USA. The study reflects Rayner’s continued focus on optimising visual outcomes for surgeons and their patients and